Main
>
ONCOLOGY (**)
>
Lymphoma>NHL>B-Cell>DLBCL R/R***
>
Treatment
>
USA. G. CD79B Marker Inhibitor+>
>
(*) USA Approval Date: 2019. 06.10.
(*) USA Approval Date: 2019. 06.10.'s products
This section has no products